RARRES1 anticorps
Aperçu rapide pour RARRES1 anticorps (ABIN7242755)
Antigène
Voir toutes RARRES1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Synthetic peptide of human RARRES1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC 1:100-1:300
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.1 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- RARRES1 (Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1))
-
Autre désignation
- RARRES1
-
Sujet
- This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed.
-
NCBI Accession
- NP_002879
-
UniProt
- P49788
Antigène
-